Fresenius Medical Care AG & Co. KGaA
FMS Healthcare Medical Care Facilities
Fresenius Medical Care AG & Co. KGaA’s revenue for fiscal 2025 (year ended December 2025) was $22.2 billion, up 6.13% from fiscal 2024.
- Revenue
- −0.49%
- EPS
- −10.6%
- Free cash flow
- −3.47%
- Total debt
- +8.09%
Quarter to September 2026, against a year earlier
Follow FMS
Alert me
Fresenius Medical Care AG & Co. KGaA (FMS) EPS (diluted)
Fresenius Medical Care AG & Co. KGaA's EPS (diluted) for fiscal 2025 was $1.90, up 93.9% from $0.98 in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.87. Over the past ten years it has ranged from $0.92 (fiscal 2023) to $3.80 (fiscal 2018); the current reading is higher than 45% of that period. Fresenius Medical Care AG & Co. KGaA ranks 12th of 48 Medical Care Facilities companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $1.90 | 93.88% |
| FY2024 | $0.98 | 6.52% |
| FY2023 | $0.92 | (23.97%) |
| FY2022 | $1.21 | (38.27%) |
| FY2021 | $1.96 | (13.27%) |
| FY2020 | $2.26 | 1.80% |
| FY2019 | $2.22 | (41.58%) |
| FY2018 | $3.80 | 61.02% |
| FY2017 | $2.36 | 16.26% |
| FY2016 | $2.03 | 20.12% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.49 | 4.68% |
| Jun 2026 | $0.47 | 88.00% |
| Mar 2026 | $0.25 | (62.12%) |
| Dec 2025 | $0.66 | 20.00% |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| THC Tenet Healthcare Corporation compare | $37.19 |
| UHS Universal Health Services, Inc. compare | $23.99 |
| CHE Chemed Corporation compare | $20.90 |
| DVA DaVita Inc. compare | $13.58 |
| ENSG The Ensign Group, Inc. compare | $6.72 |
| EHC Encompass Health Corporation compare | $6.40 |
| FMS Fresenius Medical Care AG & Co. KGaA | $1.87 |
| PACS PACS Group, Inc. compare | $1.77 |
| CON Concentra Group Holdings Parent, Inc. compare | $1.69 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on FMS
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement